These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 16948218

  • 1. [Etiology of multiple sclerosis].
    Laplaud DA, Confavreux C.
    Rev Prat; 2006 Jun 30; 56(12):1306-12. PubMed ID: 16948218
    [Abstract] [Full Text] [Related]

  • 2. [Infection by Epstein-Barr virus and multiple sclerosis].
    Alonso A, Egüés Olazábal N, Ayo Martín O.
    Neurologia; 2006 Jun 30; 21(5):249-55. PubMed ID: 16788867
    [Abstract] [Full Text] [Related]

  • 3. The destructive alliance: interactions of leukocytes, cerebral endothelial cells, and the immune cascade in pathogenesis of multiple sclerosis.
    Minagar A, Carpenter A, Alexander JS.
    Int Rev Neurobiol; 2007 Jun 30; 79():1-11. PubMed ID: 17531835
    [Abstract] [Full Text] [Related]

  • 4. The multiple sclerosis trait and the development of multiple sclerosis: genetic vulnerability and environmental effect.
    Poser CM.
    Clin Neurol Neurosurg; 2006 Mar 30; 108(3):227-33. PubMed ID: 16406307
    [Abstract] [Full Text] [Related]

  • 5. Multiple sclerosis: a complicated picture of autoimmunity.
    McFarland HF, Martin R.
    Nat Immunol; 2007 Sep 30; 8(9):913-9. PubMed ID: 17712344
    [Abstract] [Full Text] [Related]

  • 6. [Virus and demyelination: why suspect that a virus may be involved in the aetiology of multiple sclerosis?].
    Fernández-Muñoz R, Celma-Serrat M.
    Rev Neurol; 2007 Sep 30; 35(10):964-72. PubMed ID: 12436401
    [Abstract] [Full Text] [Related]

  • 7. [Multiple sclerosis: results and prospects of research].
    Zavalishin IA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982 Sep 30; 82(2):161-7. PubMed ID: 7041492
    [Abstract] [Full Text] [Related]

  • 8. Neurotrophic cross-talk between the nervous and immune systems: relevance for repair strategies in multiple sclerosis?
    Hohlfeld R.
    J Neurol Sci; 2008 Feb 15; 265(1-2):93-6. PubMed ID: 17459415
    [Abstract] [Full Text] [Related]

  • 9. [Etiology of multiple sclerosis].
    Confavreux C, Goudable B, Moreau T.
    Rev Prat; 1991 Sep 15; 41(20):1888-92. PubMed ID: 1925371
    [Abstract] [Full Text] [Related]

  • 10. Immunology of multiple sclerosis.
    Sospedra M, Martin R.
    Annu Rev Immunol; 2005 Sep 15; 23():683-747. PubMed ID: 15771584
    [Abstract] [Full Text] [Related]

  • 11. Multiple sclerosis: immunopathogenesis and controversies in defining the cause.
    Holmøy T, Hestvik AL.
    Curr Opin Infect Dis; 2008 Jun 15; 21(3):271-8. PubMed ID: 18448972
    [Abstract] [Full Text] [Related]

  • 12. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis.
    Hohlfeld R, Kerschensteiner M, Stadelmann C, Lassmann H, Wekerle H.
    Neurol Sci; 2006 Mar 15; 27 Suppl 1():S1-7. PubMed ID: 16708174
    [Abstract] [Full Text] [Related]

  • 13. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL, Wiendl H.
    Hum Immunol; 2008 Nov 15; 69(11):797-804. PubMed ID: 18723060
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?
    Johnson AJ, Suidan GL, McDole J, Pirko I.
    Int Rev Neurobiol; 2007 Nov 15; 79():73-97. PubMed ID: 17531838
    [Abstract] [Full Text] [Related]

  • 16. CD8+ T cells in inflammatory demyelinating disease.
    Weiss HA, Millward JM, Owens T.
    J Neuroimmunol; 2007 Nov 15; 191(1-2):79-85. PubMed ID: 17920696
    [Abstract] [Full Text] [Related]

  • 17. Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease.
    Bowen JL, Olson JK.
    J Immunol; 2009 Dec 01; 183(11):6971-80. PubMed ID: 19890055
    [Abstract] [Full Text] [Related]

  • 18. Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies.
    Szczuciński A, Losy J.
    Acta Neurol Scand; 2007 Mar 01; 115(3):137-46. PubMed ID: 17295707
    [Abstract] [Full Text] [Related]

  • 19. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
    Holmøy T.
    Minerva Med; 2008 Apr 01; 99(2):119-40. PubMed ID: 18431322
    [Abstract] [Full Text] [Related]

  • 20. Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
    Stüve O, Marra CM, Bar-Or A, Niino M, Cravens PD, Cepok S, Frohman EM, Phillips JT, Arendt G, Jerome KR, Cook L, Grand'Maison F, Hemmer B, Monson NL, Racke MK.
    Arch Neurol; 2006 Oct 01; 63(10):1383-7. PubMed ID: 17030653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.